loader
Please Wait
Applying Filters...
menu
    • menu

    Setid E082d38c 3efa 4a63 8b22 20d389e78ca3 Applno 208374 Form Solution Intravenous Dosage 250mg 50ml 5mg Ml - Drug Product Composition: Bivalirudin

    Menu

    Bivalirudin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 98,575Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 208374 / DOSAGE - SOLUTION;INTRAVENOUS - 250MG/50ML (5MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BIVALIRUDIN(UNII: TN9BEX005G)
    (BIVALIRUDIN - UNII:TN9BEX005G)     		BIVALIRUDIN500mg in 100 | 250mg in 50

    Inactive Ingredients

    Ingredient Name
    Baxter Healthcare Corporation
    HYDROCHLORIC ACID(QTT17582CB)
    SODIUM CHLORIDE(451W47IQ8X)
    SODIUM HYDROXIDE(55X04QC32I)
    WATER(059QF0KO0R)